/
/
/

iSERA Lifesciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit143.90
Low (₹)0.00
Lower Circuit136.75
Prev Close143.90
52W High (₹)151.05
Price143.90
52W Low (₹)7.59

Share Market Cap & Key Ratios Overview

M.Cap (₹)121.00 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity-16.38
Price to Book0.00
Book Value-3.83
EPS (TTM)-0.07
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
TCS-ANSE
INFY-ANSE
HCLTECH-ANSE
WIPRO-ANSE
TECHM-ANSE
LTM-ANSE
OFSS-ANSE
PERSISTENT-ANSE
COFORGE-ANSE
MPHASIS-ANSE
ISERA-XTNSE
LTP
1W Low
1W High
Market cap (₹)
2077-24 (-1.14%)
2067.70
2145.25
7,54,697Cr
1009.1-41.05 (-3.91%)
1005.30
1044.45
4,13,620Cr
1244.85+6.85 (0.55%)
1238
1285.80
3,40,836Cr
163.6-2.4 (-1.45%)
163.20
166.75
1,63,233Cr
1546+15.3 (1.00%)
1524.60
1576.30
1,52,415Cr
4035-222.9 (-5.23%)
4020
4316
1,21,096Cr
10905-770 (-6.60%)
10630
11799.55
94,497Cr
5276-157 (-2.89%)
5190
5475
82,598Cr
1788+28 (1.59%)
1757.95
1818.80
78,894Cr
2251.1-58.8 (-2.55%)
2230.80
2313.35
43,097Cr
143.9+0 (0.00%)
143.90
143.90
121Cr

Key Highlights of iSERA Lifesciences Ltd Balance Sheet

iSERA Lifesciences Ltd balance sheet discloses shareholders' funds of ₹32.34Lakh as of 2025-03-31. The company’s equity share capital is at a value of ₹32.34Lakh, and the reserves and surplus of the company is -₹42.14Lakh.

The company has its non-current liabilities with total liabilities of ₹1.55Cr as of 2025-03-31.

The current liabilities are ₹4.61Lakh as of 2025-03-31. At the same time, current assets are ₹1.55Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of 0, provided in the iSERA Lifesciences Ltd financial statements.